Dr. Kent W. Small, MD

Dr. Small practices at Kent W Small, MD a Medical Corporation in Glendale, California.

Dr. Small's NPI, 1861470783, was assigned on January 3, 2006. Dr. Small graduated from Tulane School of Medicine in 1981. Dr. Small's California license number on file is A53173.

Dr. Small's primary practice is Kent W Small, MD a Medical Corporation, at 501 N Orange St, Glendale, CA 91203 in Los Angeles County. The practice phone is (818) 552-5040.

Dr. Small's primary practice is Kent W Small, MD a Medical Corporation in Glendale, California. Dmand AI also links Dr. Small to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Small practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Small's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Small is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Small's licenses on file in 7 states: California, Florida, North Carolina, Louisiana, South Carolina, Tennessee and Maryland.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eyelid inflammation, glaucoma, hypertensive retinopathy and laser destruction of retinal or choroid lesions among the conditions Dr. Small treats.

CMS data shows 85,855 Medicare services from Dr. Small across 25 procedure codes in 2024, for 1,166 Medicare patients. Medicare paid $4,035,039 for them. Every service was in an office.

CMS counts 1,166 Medicare patients who saw Dr. Small in 2024. The largest group is 75 to 84, with 491 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Small's median patient age at 74, with 56% women.

In 2024, Dr. Small wrote 2,957 Medicare Part D claims for 412 patients. CMS names the drug for 2,775 of them, across 32 drugs with 11 or more claims each, at $773,578 in total drug cost. In 2023, CMS named 2,806 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Small for performance year 2024, reported individually. Dr. Small accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 90 papers to Dr. Small, published from 1997 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Pedigree, Macular Degeneration and Fundus Oculi. Dr. Small has published most often in Am J Ophthalmol. Dr. Small's most frequent co-authors are Anthony Bart Nesburn, MD, Steven A. Agemy, MD and David S. Boyer, MD.

Dmand AI links Dr. Small to 3 clinical trials. Conditions studied include Macular Degeneration, Geographic Atrophy and Macular Edema. Open Payments lists research payments to Dr. Small that name 1 trial.

CMS Open Payments shows 927 general payments to Dr. Small from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Amgen Inc. paid the most, $3,956. It also lists 15 research payments totaling $110,845 from 2017 to 2024, naming 1 clinical trial.

Dr. Small graduated from Tulane School of Medicine in 1981.

Dr. Small is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.